Aldoril d30 and Nail pitting - a phase IV clinical study of FDA data
We study 335 people who take Aldoril d30 or have Nail pitting. No report of Nail pitting is found in people who take Aldoril d30.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Aldoril D30?
Aldoril d30 has active ingredients of hydrochlorothiazide; methyldopa. eHealthMe is studying from 5 Aldoril d30 users for its effectiveness, alternative drugs and more.
What is Nail Pitting?
Nail pitting (small dents on the surface of your nails) is found to be associated with 229 drugs and 115 conditions by eHealthMe.
Do you take Aldoril d30 and have Nail pitting?Check whether Nail pitting is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Nail pitting and when was it recovered:
Expand to all the drugs that have ingredients of hydrochlorothiazide; methyldopa:
Alternative drugs to, pros and cons of Aldoril d30:
- Aldoril d30 (5 reports)
Nail pitting treatments and more:
- Nail pitting (330 reports)
COVID vaccines that are related to Nail pitting:
- Nail pitting in Moderna COVID Vaccine
- Nail pitting in Pfizer BioNTech Covid Vaccine
- Nail pitting in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Nail pitting:
All the conditions that are associated with Nail pitting:
How the study uses the data?
The study uses data from the FDA. It is based on hydrochlorothiazide; methyldopa (the active ingredients of Aldoril d30) and Aldoril d30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amoxapine and Zopiclone drug interaction - a second ago
- Glucotrol and Oral Disorder - 2 seconds ago
- Brethaire and Narcan drug interaction - 5 seconds ago
- Losartan and Homicide - 8 seconds ago
- Stribild and Hip Joint Replacement - 12 seconds ago
- Sonata and Invega Sustenna drug interaction - 15 seconds ago
- Jentadueto and Skin - Clammy - 16 seconds ago
- Ramelteon and Zaleplon drug interaction - 20 seconds ago
- Zarxio and Posaconazole drug interaction - 25 seconds ago
- Megace and Feeling Jittery - 27 seconds ago